Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
Gene expression (GE) signatures and Tumor Infiltrating Lymphocytes (TIL) enumeration are predictive for response to neoadjuvant chemotherapy in HR- and in HER2+ breast cancer, but data are conflicting in HR+/HER2- disease. This study aimed to explore their predictive value in this subset, measured b...
Main Authors: | Alexios Matikas, John Lövrot, Anna Ramberg, Margareta Eriksson, Therese Lindsten, Tobias Lekberg, Ingrid Hedenfalk, Niklas Loman, Jonas Bergh, Thomas Hatschek, Ann Erlandsson, Theodoros Foukakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-09-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2018.1466017 |
Similar Items
-
Immune infiltrating cells in duodenal cancers
by: G. Donisi, et al.
Published: (2020-09-01) -
Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes
by: Liu S, et al.
Published: (2020-05-01) -
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications
by: Maria Vittoria Dieci, et al.
Published: (2021-01-01) -
The Landscape of Immune Cells Infiltrating in Prostate Cancer
by: Zhicong Wu, et al.
Published: (2020-10-01) -
Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01)